GE HealthCare Reports First Quarter 2026 Financial Results
GE HealthCare reported strong financial performance for the first quarter of 2026, driven by robust growth in Pharmaceutical Diagnostics and Imaging services. The company expressed satisfaction with its topline results, which met high-end expectations, according to CEO Peter Arduini.
CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2026. GE HealthCare President and CEO Peter Arduini said, “As we start the year, we’re pleased with topline performance, which came in at the high end of our expectations. Growth was driven by strong commercial execution in Pharmaceutical Diagnostics, including Flyrcado, Advanced Visualization Solutions, and Imaging, as well as services. We are maintaining our topline gr